Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.
about
Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Heteromerization of μ-opioid r ...... f cholecystokinin octapeptide.
@en
Heteromerization of μ-opioid r ...... f cholecystokinin octapeptide.
@nl
type
label
Heteromerization of μ-opioid r ...... f cholecystokinin octapeptide.
@en
Heteromerization of μ-opioid r ...... f cholecystokinin octapeptide.
@nl
prefLabel
Heteromerization of μ-opioid r ...... f cholecystokinin octapeptide.
@en
Heteromerization of μ-opioid r ...... f cholecystokinin octapeptide.
@nl
P2093
P2860
P921
P1476
Heteromerization of μ-opioid r ...... f cholecystokinin octapeptide.
@en
P2093
P2860
P2888
P356
10.1038/S12276-018-0090-5
P577
2018-05-21T00:00:00Z
P6179
1104136514